Future Science Group launches Breast Cancer Management journal

Future Science Group has announced the introduction of Breast Cancer Management, a new bimonthly journal appearing under its Future Medicine label.

The publication is designed to offer a rapid-publication platform for debate and the presentation of new findings in the field of breast cancer treatment, with its editorial board comprised of global opinion leaders in this field.

It will address key disease management issues by exploring the best patient-centred clinical research, as well as highlighting major advances in basic and translational research, and placing them in context for future therapy.

The journal's senior editors are V Craig Jordan of the Georgetown University Medical Center and Mike Dixon of the University of Edinburgh, with two associate editors and an advisory panel of 26 international experts offering support.

Elisa Manzotti, publisher at Future Medicine, said: "Breast Cancer Management will be a valuable contribution to the clinical literature and we welcome this important addition to our portfolio of journals and ebooks in the field of oncology."

Earlier this year, the publisher also launched Pharmaceutical Patent Analyst, a journal analysing new developments in patent literature relating to pharmaceutical and medical science.